Don't qualify for this program? Visit the DBAs to look for financial assistance based on your diagnosis.  
Program 1 of 3.
Scroll down to see them all.
 

Xarelto

View Coupon View Coupon

Johnson & Johnson Patient Assistance Foundation, Inc. Hospital Access Patient Assistance Program

This program provides medication at no cost.

Provided by: Johnson & Johnson Patient Assistance Foundation, Inc.


TEL: 800-652-6227


Languages Spoken:

English

Program Website

 

Program Applications and Forms

Johnson & Johnson Hospital Access Patient Assistance Program Application: Contact program

 

Medications

  • Xarelto tablet (rivaroxaban)
 

Eligibility Requirements   

Insurance Status Contact program for details.
Those with Part D Eligible? Not specified
Income Not applicable
Diagnosis/Medical Criteria Not applicable
US Residency Required? Must be residing in the US or US territory
   

Application

Obtaining Enroll online
Receiving Must apply online
Returning Not applicable
Doctor's Action Hospital must complete product request form for each replacement
Applicant's Action Not specified
Decision Communicated Not specified
Decision Timeframe Not specified
   

Medication

Amount/Supply Not specified
Sent To Hospital
Delivery Time Not specified
Refill Process Not specified
Limit Not specified
Re-application New application, new documentation yearly
   

Additional Information

This program allows eligible hospitals to receive free medications to give to qualified outpatients directly.

Contact the program for more details (1-800-652-6227).

The hospital access application is only available via the online portal.


Updated February 07, 2023


Don't qualify for this program? Visit the DBAs to look for financial assistance based on your diagnosis.  
Program 2 of 3.
Scroll down to see them all.
 

Xarelto

View Coupon View Coupon

Johnson & Johnson Patient Assistance Foundation, Inc. Patient Assistance Program

This program provides medication at no cost.

Provided by: Johnson & Johnson Patient Assistance Foundation, Inc.

PO Box 0367
Chesterfield, MO 63006

TEL: 800-652-6227


FAX: 888-526-5168
Languages Spoken:

English, Spanish, Others By Translation Service

Program Website

 

Program Applications and Forms

Johnson & Johnson Patient Assistance Foundation, Inc. Patient Application

Johnson & Johnson Patient Assistance Foundation, Inc. Patient Application: Imbruvica

 

Medications

  • Xarelto oral suspension (rivaroxaban)
  • Xarelto tablet (rivaroxaban)
 

Eligibility Requirements   

Insurance Status Contact program for details.
Those with Part D Eligible? Contact program for details.
Income Varies. *See below for details
Diagnosis/Medical Criteria Medication must be for outpatient use only
US Residency Required? Must reside permanently in the US or US territories
   

Application

Obtaining Call or download
Receiving Faxed, mailed or downloaded from website
Returning Fax or mail
Doctor's Action Complete section and sign
Applicant's Action Complete section, sign, attach required documents
Decision Communicated Patient and Doctor are notified
Decision Timeframe 3-5 business days
   

Medication

Amount/Supply Not specified
Sent To Doctor's office or patient is sent card to be used at pharmacy
Delivery Time Varies
Refill Process Varies per medication
Limit Varies
Re-application New application, new documentation yearly
   

Additional Information

*Please call (1-800-652-6227 or visit Program website for specific FPL income requirements.

Updated February 07, 2023


Don't qualify for this program? Visit the DBAs to look for financial assistance based on your diagnosis.  
Program 3 of 3.
 

Xarelto

View Coupon View Coupon

Janssen Support Program

This program provides brand name medications at no or low cost

Provided by: Johnson & Johnson Health Care Systems Inc. (JJHCS)


TEL: 833-742-0791


FAX: 833-512-0497
Languages Spoken:

English

Program Website

 

Program Applications and Forms

Janssen Support Program Patient Authorization

Janssen Support Program Patient Authorization (electronically sign)

 

Medications

  • Xarelto oral suspension (rivaroxaban)
  • Xarelto tablet (rivaroxaban)
 

Eligibility Requirements   

Insurance Status Must have insurance
Those with Part D Eligible? Determined case by case
Income Based on FPL
Diagnosis/Medical Criteria FDA-approved diagnosis
US Residency Required? Must reside permanently in the US or US territories
   

Application

Obtaining Call, download or apply online
Receiving Complete online, download from website or faxed.
Returning Fax
Doctor's Action Complete section, sign, attach required documents
Applicant's Action Complete section, sign, attach required documents
Decision Communicated Patient and Doctor are notified
Decision Timeframe Varies
   

Medication

Amount/Supply Varies
Sent To Varies
Delivery Time Varies
Refill Process Varies per medication
Limit Varies
Re-application New application, new documentation yearly
   

Additional Information

This program may provide a Bridge Program for eligible patients who experience a delay, temporary loss, or change in coverage. Contact program for details.

Updated January 25, 2023